AbSorber
Related
Latest news
-
2010-06-03
AbSorber AB hosts an early morning symposium at The Transplant Society (TTS) World Congress in Vancouver, August 16. -
2010-05-07
At the American Transplant Congress in San Diego the organizers held a workshop of the subject of Endothelial Cell Crossmatch. -
2010-03-01
AbSorber strengthen its position on the important US market by acquiring NorDiag’s share of Olerup Inc. AbSorber buys the company together with SSP Primers and after the transition will AbSorber own 50 percent of Olerup Inc. and SSP Primers 50 percent. -
2009-12-09
AbSorber receives European patent protection for its transplantation cross match-test XM-ONE®
Company history
AbSorber is an innovative biotech company dedicated to bring value to the transplant community. The company was founded in 1999 based on inventions made by Associate Professor Jan Holgersson at the Department of Clinical Immunology and Professor Suchitra Holgersson at the Department of Transplantation Surgery at Sahlgrenska University Hospital, Gothenburg, Sweden.
AbSorber’s research is focused on developing products for allogeneic transplantation. XM-ONE®, AbSorbers first product to market, was registered within the EU in 2006 and received FDA registration in late 2008. It is currently used for enhanced risk assessement before transplantation.
Other research areas includes development of tools in transplantation across blood group barriers, i.e. ABO incompatible transplantation.